Resource Utilization and Costs Associated with Approaches to Identify Infants with Early-Onset Sepsis

Grace Guan1, Neha S Joshi2, Adam Frymoyer2

  • 1Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.

MDM Policy & Practice
|January 31, 2024
PubMed

Insights

The neonatal sepsis calculator and enhanced clinical observation are preferred for identifying early-onset sepsis (EOS) in newborns. These methods reduce infant antibiotic exposure and interventions compared to categorical risk assessment, despite similar overall costs.

Area of Science:

  • Neonatal medicine
  • Public health
  • Health economics

Background:

  • The American Academy of Pediatrics (AAP) recommends 3 approaches for identifying early-onset sepsis (EOS) in infants born at ≥35 weeks gestational age.
  • Evaluating resource utilization and costs of these screening methods is crucial for healthcare systems.

Purpose of the Study:

  • To compare resource utilization and costs of 3 AAP-recommended screening approaches for early-onset sepsis (EOS).
  • To identify the most cost-effective and resource-efficient screening strategy for EOS.

Main Methods:

  • Decision tree-based cost analysis comparing 3 AAP-recommended EOS screening approaches: categorical risk assessment, neonatal sepsis calculator, and enhanced clinical observation.
  • Evaluation of resource utilization (e.g., NICU days) and direct health system costs in 2022 US dollars.

Main Results:

  • Categorical risk assessment resulted in higher NICU usage (210 days/1,000 live births) and antibiotic exposure (6.8%) compared to the neonatal sepsis calculator (112 days/1,000 live births, 3.6%) and enhanced clinical observation (99 days/1,000 live births, 3.1%).
  • While per-live birth costs were similar ($1,360 vs $1,317 vs $1,310), intervention costs under categorical risk assessment were double those of the other two strategies.
  • Results remained robust across data variations.

Conclusions:

  • Neonatal sepsis calculator and enhanced clinical observation are preferable to categorical risk assessment for EOS screening.
  • These preferred approaches reduce infant intervention rates, antibiotic exposure, and associated costs.
  • Further cost-effectiveness analyses should consider downstream effects of neonatal antibiotic exposure.